Not Tagged
roche
['hcc', 'genesis,(-pathogenesis),(-carginogenesis)', 'genentech']
great interaction &amp; interest in our session "the future of antiangiogenesis in the era of immunotherapy? (with - chair rakesh jain). recent genentech study shows 38% improvement as adjuvant therapy in recurrence-free survival in hccpatients after resection #aacr2023 